BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8422382)

  • 1. Inhibition of bovine lens leucine aminopeptidase by bestatin: number of binding sites and slow binding of this inhibitor.
    Taylor A; Peltier CZ; Torre FJ; Hakamian N
    Biochemistry; 1993 Jan; 32(3):784-90. PubMed ID: 8422382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of azidobestatin as a photoaffinity label to identify the active site peptide of leucine aminopeptidase.
    Taylor A; Peltier CZ; Jahngen EG; Laxman E; Szewczuk Z; Torre FJ
    Biochemistry; 1992 Apr; 31(16):4141-50. PubMed ID: 1567860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The slow, tight binding of bestatin and amastatin to aminopeptidases.
    Wilkes SH; Prescott JM
    J Biol Chem; 1985 Oct; 260(24):13154-62. PubMed ID: 2865258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray crystallographic determination of the structure of bovine lens leucine aminopeptidase complexed with amastatin: formulation of a catalytic mechanism featuring a gem-diolate transition state.
    Kim H; Lipscomb WN
    Biochemistry; 1993 Aug; 32(33):8465-78. PubMed ID: 8357796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis.
    Burley SK; David PR; Lipscomb WN
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):6916-20. PubMed ID: 1871107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-refinement of the X-ray crystal structure of bovine lens leucine aminopeptidase complexed with bestatin.
    Kim H; Burley SK; Lipscomb WN
    J Mol Biol; 1993 Apr; 230(3):722-4. PubMed ID: 8478928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition state analogue L-leucinephosphonic acid bound to bovine lens leucine aminopeptidase: X-ray structure at 1.65 A resolution in a new crystal form.
    Sträter N; Lipscomb WN
    Biochemistry; 1995 Jul; 34(28):9200-10. PubMed ID: 7619821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure determination and refinement of bovine lens leucine aminopeptidase and its complex with bestatin.
    Burley SK; David PR; Sweet RM; Taylor A; Lipscomb WN
    J Mol Biol; 1992 Mar; 224(1):113-40. PubMed ID: 1548695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectroscopic and X-ray crystallographic characterization of bestatin bound to the aminopeptidase from Aeromonas (Vibrio) proteolytica.
    Stamper CC; Bienvenue DL; Bennett B; Ringe D; Petsko GA; Holz RC
    Biochemistry; 2004 Aug; 43(30):9620-8. PubMed ID: 15274616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes.
    Rich DH; Moon BJ; Harbeson S
    J Med Chem; 1984 Apr; 27(4):417-22. PubMed ID: 6142952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of leucine aminopeptidase and aminopeptidase III activities in lens.
    Sharma KK; Elser NJ; Kester K
    Curr Eye Res; 1996 Jul; 15(7):774-81. PubMed ID: 8670787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterization and structural prediction of a novel cytosolic leucyl aminopeptidase of the M17 family from Schizosaccharomyces pombe.
    Herrera-Camacho I; Rosas-Murrieta NH; Rojo-Domínguez A; Millán L; Reyes-Leyva J; Santos-López G; Suárez-Rendueles P
    FEBS J; 2007 Dec; 274(23):6228-40. PubMed ID: 18028193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-metal ion mechanism of bovine lens leucine aminopeptidase: active site solvent structure and binding mode of L-leucinal, a gem-diolate transition state analogue, by X-ray crystallography.
    Sträter N; Lipscomb WN
    Biochemistry; 1995 Nov; 34(45):14792-800. PubMed ID: 7578088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucine aminopeptidase (bovine lens): synthesis and kinetic properties of ortho-, meta-, and para-substituted leucyl-anilides.
    Taylor A; Tisdell FE; Carpenter FH
    Arch Biochem Biophys; 1981 Aug; 210(1):90-7. PubMed ID: 7294838
    [No Abstract]   [Full Text] [Related]  

  • 15. Differentiation and identification of the two catalytic metal binding sites in bovine lens leucine aminopeptidase by x-ray crystallography.
    Kim H; Lipscomb WN
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5006-10. PubMed ID: 8506345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic implications of the inhibition of peptidases by amino aldehydes and bestatin.
    Frick L; Wolfenden R
    Biochim Biophys Acta; 1985 Jul; 829(3):311-8. PubMed ID: 3890953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of fiber cell globulization and hyperglycemia-induced lens opacification by aminopeptidase inhibitor bestatin.
    Chandra D; Ramana KV; Wang L; Christensen BN; Bhatnagar A; Srivastava SK
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2285-92. PubMed ID: 12091429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine-lens leucine aminopeptidase. Kinetic studies with substrates and substrate-like inhibitors.
    Fittkau S; Förster U; Pascual C; Schunck WH
    Eur J Biochem; 1974 May; 44(2):523-8. PubMed ID: 4838681
    [No Abstract]   [Full Text] [Related]  

  • 19. Aminopeptidases: structure and function.
    Taylor A
    FASEB J; 1993 Feb; 7(2):290-8. PubMed ID: 8440407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of a leucyl aminopeptidase from three pathogenic Leishmania species.
    Morty RE; Morehead J
    J Biol Chem; 2002 Jul; 277(29):26057-65. PubMed ID: 12006595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.